scholarly journals 207: CORTICOSTEROID TREATMENT RESPONSE IN HOSPITALIZED COVID-19 PATIENTS

2021 ◽  
Vol 50 (1) ◽  
pp. 87-87
Author(s):  
Stephanie Williams ◽  
Natalia Lattanzio ◽  
Richard Walo ◽  
Karen Hamad ◽  
Wilhelmine Wiese-Rometsch ◽  
...  
2017 ◽  
Vol 38 (3) ◽  
pp. 197-203 ◽  
Author(s):  
Sara Manti ◽  
Salvatore Leonardi ◽  
Giuseppe F. Parisi ◽  
Dominique De Vivo ◽  
Annamaria Salpietro ◽  
...  

2010 ◽  
Vol 4 (2) ◽  
pp. 67-73 ◽  
Author(s):  
Minna Purokivi ◽  
Heikki Koskela ◽  
Tiina Koistinen ◽  
Keijo Peuhkurinen ◽  
Kirsi Maarit Kontra

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0186150 ◽  
Author(s):  
Xue Zhang ◽  
Jocelyn M. Biagini Myers ◽  
Veda K. Yadagiri ◽  
Ashley Ulm ◽  
Xiaoting Chen ◽  
...  

2015 ◽  
Vol 136 (4) ◽  
pp. 923-931.e3 ◽  
Author(s):  
Chang Xiao ◽  
Jocelyn M. Biagini Myers ◽  
Hong Ji ◽  
Kelly Metz ◽  
Lisa J. Martin ◽  
...  

Author(s):  
Frank Häßler ◽  
Olaf Reis ◽  
Steffen Weirich ◽  
Jacqueline Höppner ◽  
Birgit Pohl ◽  
...  

This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine. Under a combined treatment with amantadine, electroconvulsive therapy (ECT), and (currently) ziprasidone alone she improved markedly. Severity and course of catatonia including treatment response were evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). This case report emphasizes the benefit of ECT in the treatment of catatonic symptoms in an adolescent patient with schizophrenic illness.


Sign in / Sign up

Export Citation Format

Share Document